Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Nom du journal : Clin Trials

Année : 2009

Volume : 6

Page de départ : 272

Page de fin : 286

Auteurs: Giobbie-Hurder A, Price KN, Gelber RD, for the International Breast Cancer Study Group and BIG 1-98 Collaborative Group, Fournier M,